Pierre Roy
ceo
Technical Director
Project Manager Infectious Diseases & Respiratory at PPD
France
Biography
CEO and co-founder of OPIA Technologies SAS, developing biomarkers-based diagnosis devices for the diagnosis of ocular surface diseases and drug delivery devices for the eye. OPIA is marketing a conjunctival impression device, EyePrim, for sampling ocular surface components to serve as a platform for innovative diagnosis techniques of ocular surface diseases (dry eye, allergy, infections) and is developing a patented tear film sampling platform for complementary ocular surface diagnosis techniques
Research Interest
CEO and co-founder of OPIA Technologies SAS, developing biomarkers-based diagnosis devices for the diagnosis of ocular surface diseases and drug delivery devices for the eye. OPIA is marketing a conjunctival impression device, EyePrim, for sampling ocular surface components to serve as a platform for innovative diagnosis techniques of ocular surface diseases (dry eye, allergy, infections) and is developing a patented tear film sampling platform for complementary ocular surface diagnosis techniques
